Ignite Creation Date:
2024-05-06 @ 3:58 AM
Last Modification Date:
2024-10-26 @ 11:41 AM
Study NCT ID:
NCT02419742
Status:
COMPLETED
Last Update Posted:
2022-10-12
First Post:
2015-03-23
Brief Title:
Safety and Efficacy of Trastuzumab as Part of Breast Cancer Treatment Regimen
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-08-18
Start Date Type:
ACTUAL
Primary Completion Date:
2021-06-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-06-24
Completion Date Type:
ACTUAL
First Submit Date:
2015-03-23
First Submit QC Date:
April 14 2015
Study First Post Date:
2015-04-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2022-10-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-15
Last Update Post Date:
2022-10-12
Last Update Post Date Type:
ACTUAL